These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6604070)

  • 21. Microbiological perspectives of co-trimoxazole.
    Bauernfeind A; Hörl G; Przyklenk B
    Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
    Schaeffer AJ; Sisney GA
    J Urol; 1985 Apr; 133(4):628-30. PubMed ID: 3157008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sensitivity of enterobacteriaceae to sulfamethoxazole (SMZ), trimethoprim (TMP) and cotrimexazole (SMZ plus TMP)].
    Lynch B; Valenzuela MC; Donoso E; Cofre J; Vilches A; Aguero ME
    Rev Chil Pediatr; 1975; 46(1):17-9. PubMed ID: 1178944
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
    Pancoast SJ; Hyams DM; Neu HC
    Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
    Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
    Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro comparative study of Lidaprim and co-trimoxazole.
    Abdel-Messih EF; Suleiman MN; Baron JM
    J Int Med Res; 1984; 12(3):219-20. PubMed ID: 6376211
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.
    Toivanen A; Kasan A; Sundquist H; Toivanen P
    Chemotherapy; 1976; 22(2):97-103. PubMed ID: 1253636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of thymidine for the activity of trimethoprim, sulfonamides and their combinations.
    Then RL
    Zentralbl Bakteriol A; 1980; 247(4):483-94. PubMed ID: 7006266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    J Antimicrob Chemother; 2014 Apr; 69(4):1050-6. PubMed ID: 24257317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 32. Exogenous thymidine and reversal of the inhibitory effect of sulfamethoxazole-trimethoprim on streptococci.
    Coll PF; Ausina VR; Vernis JV; Mirelis BO; Prats GP
    Eur J Clin Microbiol; 1984 Oct; 3(5):424-6. PubMed ID: 6238821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trimethoprim-resistant coliforms.
    Lacey RW; Bruten DM; Gillespie WA; Lewis EL
    Lancet; 1972 Feb; 1(7747):409-10. PubMed ID: 4110643
    [No Abstract]   [Full Text] [Related]  

  • 35. Trimethoprim resistance and single-agent use.
    Maskell R; Pead L
    Lancet; 1989 Sep; 2(8662):557-8. PubMed ID: 2570249
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole.
    Spicehandler J; Pollock AA; Simberkoff MS; Rahal JJ
    Rev Infect Dis; 1982; 4(2):562-5. PubMed ID: 6981172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.
    Wilson JM; Guiney DG
    N Engl J Med; 1982 Jan; 306(1):16-20. PubMed ID: 7053467
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
    Goodhart GL
    JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole.
    Indiveri MC; Hirsh DC
    J Am Vet Med Assoc; 1986 Jan; 188(1):46-8. PubMed ID: 3484737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cinoxacin and trimethoprim-sulfamethoxazole in the treatment of urinary tract infections.
    Schaeffer AJ; Flynn S; Jones J
    J Urol; 1981 Jun; 125(6):825-7. PubMed ID: 7241682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.